Detalhe da pesquisa
1.
Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
Clin Infect Dis
; 71(4): 1022-1029, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31617568